Dysgerminoma - 7 Studies Found Completed : Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) : Dysgerminoma : 2005-09-13 : Drug: Darbepoetin alfa Recruiting : Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors : Germ Cell Tumor Nonseminomatous Germ Cell Tumor Seminoma : 2017-05-16 : Drug: Durvalumab 1500 mg by IV Terminated : Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer : Ovarian Dysgerminoma Recurrent Malignant Testicular Germ Cell T : 2002-08-05 : Drug: imatinib mesylate Given Active, not recruiting : Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy : Cognitive Side Effects of Cancer Therapy Malignant Ovarian Epithelial Tumor Procedure: Cognitive Assessment Completed : Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors : Brain and Central Nervous System Tumors Extragonadal Germ Cell Tumor Biological: pegfilgrastim Drug: cisplatin Completed : Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment : Extragonadal Germ Cell Tumor Ovarian Cancer Teratoma : 2007-03-27 : Drug: sunitinib malate Completed : Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors : Bladder Cancer Brain and Central Nervous System Tumors Bre : 2006-04-11 : Drug: lapatinib Other Names: